DKDRF Quote, Financials, Valuation and Earnings

Givot Olam Oil Exploration LP (1993) has a net margin of 53.79% compared to Newmed Energy LP's net margin of --. Newmed Energy LP's return on equity of 24.33% beat Givot Olam Oil Exploration LP (1993)'s return on equity of --.

Newmed Energy LP has a consensus price target of --, signalling downside risk potential of --. On the other hand Givot Olam Oil Exploration LP (1993) has an analysts' consensus of -- which suggests that it could fall by --. Given that Newmed Energy LP has higher upside potential than Givot Olam Oil Exploration LP (1993), analysts believe Newmed Energy LP is more attractive than Givot Olam Oil Exploration LP (1993).

Newmed Energy LP has a beta of 0.974, which suggesting that the stock is 2.562% less volatile than S&P 500. In comparison Givot Olam Oil Exploration LP (1993) has a beta of -161.705, suggesting its less volatile than the S&P 500 by 16270.548%.

Newmed Energy LP has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. Givot Olam Oil Exploration LP (1993) offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Newmed Energy LP pays 47.27% of its earnings as a dividend. Givot Olam Oil Exploration LP (1993) pays out -- of its earnings as a dividend. Newmed Energy LP's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Newmed Energy LP quarterly revenues are $238.9M, which are larger than Givot Olam Oil Exploration LP (1993) quarterly revenues of --. Newmed Energy LP's net income of $128.5M is higher than Givot Olam Oil Exploration LP (1993)'s net income of --. Notably, Newmed Energy LP's price-to-earnings ratio is 15.54x while Givot Olam Oil Exploration LP (1993)'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Newmed Energy LP is 7.91x versus -- for Givot Olam Oil Exploration LP (1993). Usually stocks with elevated PS ratios are considered overvalued.

Isramco Negev 2 LP has a net margin of 53.79% compared to Newmed Energy LP's net margin of 21.36%. Newmed Energy LP's return on equity of 24.33% beat Isramco Negev 2 LP's return on equity of 18.08%.

Newmed Energy LP has a consensus price target of --, signalling downside risk potential of --. On the other hand Isramco Negev 2 LP has an analysts' consensus of -- which suggests that it could fall by --. Given that Newmed Energy LP has higher upside potential than Isramco Negev 2 LP, analysts believe Newmed Energy LP is more attractive than Isramco Negev 2 LP.

Newmed Energy LP has a beta of 0.974, which suggesting that the stock is 2.562% less volatile than S&P 500. In comparison Isramco Negev 2 LP has a beta of -0.045, suggesting its less volatile than the S&P 500 by 104.457%.

Newmed Energy LP has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. Isramco Negev 2 LP offers a yield of 7.58% to investors and pays a quarterly dividend of $0.02 per share. Newmed Energy LP pays 47.27% of its earnings as a dividend. Isramco Negev 2 LP pays out 76.22% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Newmed Energy LP quarterly revenues are $238.9M, which are larger than Isramco Negev 2 LP quarterly revenues of $103.1M. Newmed Energy LP's net income of $128.5M is higher than Isramco Negev 2 LP's net income of $22M. Notably, Newmed Energy LP's price-to-earnings ratio is 15.54x while Isramco Negev 2 LP's PE ratio is 15.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Newmed Energy LP is 7.91x versus 4.03x for Isramco Negev 2 LP. Usually stocks with elevated PS ratios are considered overvalued.

Oil Refineries Ltd. has a net margin of 53.79% compared to Newmed Energy LP's net margin of 3.89%. Newmed Energy LP's return on equity of 24.33% beat Oil Refineries Ltd.'s return on equity of -0.24%.

Newmed Energy LP has a consensus price target of --, signalling downside risk potential of --. On the other hand Oil Refineries Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Newmed Energy LP has higher upside potential than Oil Refineries Ltd., analysts believe Newmed Energy LP is more attractive than Oil Refineries Ltd..

Newmed Energy LP has a beta of 0.974, which suggesting that the stock is 2.562% less volatile than S&P 500. In comparison Oil Refineries Ltd. has a beta of 0.065, suggesting its less volatile than the S&P 500 by 93.502%.

Newmed Energy LP has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. Oil Refineries Ltd. offers a yield of 8.56% to investors and pays a quarterly dividend of $0.02 per share. Newmed Energy LP pays 47.27% of its earnings as a dividend. Oil Refineries Ltd. pays out 70.75% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Newmed Energy LP quarterly revenues are $238.9M, which are smaller than Oil Refineries Ltd. quarterly revenues of $1.2B. Newmed Energy LP's net income of $128.5M is higher than Oil Refineries Ltd.'s net income of $46M. Notably, Newmed Energy LP's price-to-earnings ratio is 15.54x while Oil Refineries Ltd.'s PE ratio is 20.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Newmed Energy LP is 7.91x versus 0.16x for Oil Refineries Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Ratio Energies LP has a net margin of 53.79% compared to Newmed Energy LP's net margin of 45.49%. Newmed Energy LP's return on equity of 24.33% beat Ratio Energies LP's return on equity of 26.58%.

Newmed Energy LP has a consensus price target of --, signalling downside risk potential of --. On the other hand Ratio Energies LP has an analysts' consensus of -- which suggests that it could fall by --. Given that Newmed Energy LP has higher upside potential than Ratio Energies LP, analysts believe Newmed Energy LP is more attractive than Ratio Energies LP.

Newmed Energy LP has a beta of 0.974, which suggesting that the stock is 2.562% less volatile than S&P 500. In comparison Ratio Energies LP has a beta of -0.141, suggesting its less volatile than the S&P 500 by 114.147%.

Newmed Energy LP has a quarterly dividend of $0.05 per share corresponding to a yield of 3.47%. Ratio Energies LP offers a yield of 33.05% to investors and pays a quarterly dividend of $0.04 per share. Newmed Energy LP pays 47.27% of its earnings as a dividend. Ratio Energies LP pays out 49.68% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Newmed Energy LP quarterly revenues are $238.9M, which are larger than Ratio Energies LP quarterly revenues of $76.3M. Newmed Energy LP's net income of $128.5M is higher than Ratio Energies LP's net income of $34.7M. Notably, Newmed Energy LP's price-to-earnings ratio is 15.54x while Ratio Energies LP's PE ratio is 3.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Newmed Energy LP is 7.91x versus 1.41x for Ratio Energies LP. Usually stocks with elevated PS ratios are considered overvalued.